Predicting lung cancer by detecting aberrant promoter methylation in sputum.

By W. Palmisano, K. Divine, G. Saccomanno, Frank D. Gilliland, S. Baylin, J. Herman, S. Belinsky. Cancer Research, 2000

861 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/12c2231ca96e4707a808e5dd84ae4151ad24dd32

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. S. Baylin
2. Manel Esteller
3. J. Herman
4. Kornel E. Schuebel
5. K. Bachman
6. M. R. Rountree
7. Peter A. Jones
8. Peter W. Laird

Citations in the corpus

• Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours (2002, background): “67 and the example provided in Figure 3), and sputum [68], to mention a few.”
• Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. (2001, background): “Particularly exciting are recent studies of lung cancer patients where one of two hypermethylation loci were always positive in both tumor and sputum DNA, and were detected in the latter samples up to 3 years prior to clinical diagnosis (68).”